op 2507 has been researched along with Experimental Hepatoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawamoto, T; Kurata, M; Ohkohchi, N; Okajima, K; Uchiba, M | 1 |
| Irita, K; Isobe, H; Nawata, H; Sakai, H; Yamakawa, M; Yoshitake, JA | 1 |
2 other study(ies) available for op 2507 and Experimental Hepatoma
| Article | Year |
|---|---|
Antithrombin reduces reperfusion-induced hepatic metastasis of colon cancer cells.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antithrombins; Arginine; Cell Line, Tumor; Colonic Neoplasms; E-Selectin; Epoprostenol; Fibrin Fibrinogen Degradation Products; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; Pipecolic Acids; Rats; Rats, Inbred F344; Reperfusion; RNA, Messenger; Sulfonamides; Tumor Necrosis Factor-alpha | 2006 |
The effect of OP 2507, a stable analogue of prostacyclin, on Hep G2 exposed to hypoxia.
Topics: Animals; Cell Line; Drug Evaluation, Preclinical; Epoprostenol; Hypoxia; Kinetics; L-Lactate Dehydrogenase; Lactates; Liver Neoplasms, Experimental; Mitochondria; Organ Preservation; Rats | 1990 |